Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease (MAPUS)
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Sponsor: RedHill Biopharma Limited
This PHASE3 trial investigates Crohn's Disease and is currently completed. RedHill Biopharma Limited leads this study, which shows 24 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
24 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
▶ Show 19 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Aug 2020 — Nov 2020 [monthly]
Completed PHASE3
-
Jul 2020 — Aug 2020 [monthly]
Completed PHASE3
-
Jun 2020 — Jul 2020 [monthly]
Completed PHASE3
-
Feb 2020 — Jun 2020 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Apr 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE3
-
Nov 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE3
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Dec 2017 — May 2018 [monthly]
Active Not Recruiting PHASE3
-
Nov 2017 — Dec 2017 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Aug 2017 — Nov 2017 [monthly]
Recruiting PHASE3
-
Jul 2017 — Aug 2017 [monthly]
Recruiting PHASE3
-
Jun 2017 — Jul 2017 [monthly]
Recruiting PHASE3
-
May 2017 — Jun 2017 [monthly]
Recruiting PHASE3
-
Apr 2017 — May 2017 [monthly]
Recruiting PHASE3
-
Feb 2017 — Apr 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- RedHill Biopharma Limited
For direct contact, visit the study record on ClinicalTrials.gov .